Evidence map›Paper›PMID 37482691›Full record

ArticleJournal of diabetes science and technology2024

Designing the Continuous Glucose Monitor Experience: An App Design Process Overview.

Doug Kanter, Phil Henzler, Andrea Jackson, Alex Diener

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Doug KanterDexcom, Inc., San Diego, CA, USA.ORCID 0000-0002-2889-9914
Phil HenzlerDexcom, Inc., San Diego, CA, USA.
Andrea JacksonDexcom, Inc., San Diego, CA, USA.
Alex DienerDexcom, Inc., San Diego, CA, USA.
Dexcom (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Users of continuous glucose monitors (CGMs) experience the product in part through software. Smartphone and watch apps empower people affected by diabetes to make real-time treatment decisions based on glucose readings and aggregate data such as medication, nutrition, and activity information. As CGMs evolve and gain greater market adoption, there's opportunity for these apps to play a greater role in users' lives and diabetes management. To do so, designers should follow the best practices established by the broader technology community and apply them to the needs of this community. The process of thorough discovery research, clear problem definition, iterative design, and testing can lower barriers toward broader adoption, and favorably influence the health of users through their mobile apps.

Indexed as

Continuous Glucose MonitoringDiabetes MellitusMobile ApplicationsBlood GlucoseHumansSelf CareSmartphoneSoftware DesignBlood GlucoseCGMdesignDexcom G7mobile applicationuser experience

Identifiers

PMID37482691
PMCPMC10899853
OpenAlexW4385186068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.